Perceptive Advisors LLC
- SEC CIK
- 0001224962
- 最新申報
- 2026/8/14
2021 年第 3 季持倉
持倉截至 2021/9/30，2021/12/3 申報。只含多頭部位，變化是跟 2021 年第 2 季比股數。
- 持股檔數
- 138
- 較 2021 年第 2 季 −10
- 總值
- $68.6 億
- 較 2021 年第 2 季 −$8.27 億 (−10.8%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| MRTXMirati Therapeutics, Inc. | COM | 3,387,745 | $5.99 億 | 8.7% | +201,847+6.3% | 加碼 | 歷史 |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $4.55 億 | 6.6% | – | – | – |
| BBIOBridgeBio Pharma, Inc. | COM | 7,756,928 | $3.64 億 | 5.3% | 00.0% | 不變 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 4,849,912 | $3.08 億 | 4.5% | 00.0% | 不變 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 11,489,772 | $2.83 億 | 4.1% | +530,000+4.8% | 加碼 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 26,559,443 | $2.54 億 | 3.7% | +3,438,114+14.9% | 加碼 | 歷史 |
| LABPLandos Biopharma, Inc. | COM | 14,869,915 | $2.17 億 | 3.2% | 00.0% | 不變 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 1,956,940 | $2.14 億 | 3.1% | −28,062−1.4% | 減碼 | 歷史 |
| Collegium Pharmaceutical, Inc19459JAA2 | NOTE 2.625% 2/1 | – | $1.80 億 | 2.6% | – | – | – |
| VBIVVBI Vaccines Inc/BC | COM NEW | 55,042,465 | $1.71 億 | 2.5% | 00.0% | 不變 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 5,086,727 | $1.50 億 | 2.2% | +443,632+9.6% | 加碼 | 歷史 |
| Nevro Corp64157FAC7 | NOTE 2.750% 4/0 | – | $1.26 億 | 1.8% | – | – | – |
| ISEEIVERIC bio, Inc. | COM | 7,471,798 | $1.21 億 | 1.8% | +2,886,286+62.9% | 加碼 | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 4,407,399 | $1.12 億 | 1.6% | +254,710+6.1% | 加碼 | 歷史 |
| NVTAInvitae Corp | COM | 3,923,741 | $1.12 億 | 1.6% | −895,060−18.6% | 減碼 | 歷史 |
| ZYMEZymeworks Inc. | COM | 3,679,845 | $1.07 億 | 1.6% | −625,755−14.5% | 減碼 | 歷史 |
| CCCCC4 Therapeutics, Inc. | COM STK | 2,258,566 | $1.01 億 | 1.5% | 00.0% | 不變 | 歷史 |
| OMOutset Medical, Inc. | COM | 1,990,633 | $9,842 萬 | 1.4% | −396,902−16.6% | 減碼 | 歷史 |
| MGTXMeiraGTx Holdings plc | COM | 6,948,277 | $9,158 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 2,907,565 | $9,028 萬 | 1.3% | +431,905+17.4% | 加碼 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 9,903,879 | $8,696 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 3,963,517 | $8,343 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| AVIRAtea Pharmaceuticals, Inc. | COM | 2,259,224 | $7,921 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| RXDXPrometheus Biosciences, Inc. | COM | 3,314,032 | $7,858 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| CHRSCoherus Oncology, Inc. | COM | 4,779,387 | $7,681 萬 | 1.1% | +81,775+1.7% | 加碼 | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 2,360,139 | $7,364 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 2,310,261 | $6,905 萬 | 1.0% | −441,342−16.0% | 減碼 | 歷史 |
| PRCTPROCEPT BioRobotics Corp | COM | 1,656,990 | $6,321 萬 | 0.9% | +1,656,990 | 新進 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 1,943,097 | $6,127 萬 | 0.9% | −75,000−3.7% | 減碼 | 歷史 |
| ICVXIcosavax, Inc. | COM | 1,922,549 | $5,689 萬 | 0.8% | +1,922,549 | 新進 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 8,911,151 | $5,471 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| KRONKronos Bio, Inc. | COM | 2,421,142 | $5,075 萬 | 0.7% | −106,910−4.2% | 減碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 887,340 | $5,026 萬 | 0.7% | −50,800−5.4% | 減碼 | 歷史 |
| Coherus Biosciences Inc19249HAB9 | NOTE 1.500% 4/1 | – | $4,937 萬 | 0.7% | – | – | – |
| TVTXTravere Therapeutics, Inc. | COM | 1,965,555 | $4,767 萬 | 0.7% | +120,000+6.5% | 加碼 | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 537,635 | $4,678 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 483,007 | $4,633 萬 | 0.7% | −328,825−40.5% | 減碼 | 歷史 |
| VRCAVerrica Pharmaceuticals Inc. | COM | 3,610,412 | $4,513 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| MGNXMacrogenics Inc | COM | 2,148,060 | $4,498 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| KODKodiak Sciences Inc. | COM | 461,248 | $4,427 萬 | 0.6% | +175,207+61.3% | 加碼 | 歷史 |
| ATNXAthenex, Inc. | COM | 13,532,467 | $4,073 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| VERUVeru Inc. | COM | 4,451,342 | $3,797 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| Rain Oncology Inc.75082Q105 | COM | 2,537,019 | $3,795 萬 | 0.6% | 00.0% | 不變 | – |
| QTNTQuotient Ltd | SHS | 16,200,818 | $3,791 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 7,695,505 | $3,771 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 1,121,490 | $3,736 萬 | 0.5% | +214,400+23.6% | 加碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 505,541 | $3,619 萬 | 0.5% | −194,867−27.8% | 減碼 | 歷史 |
| OMICSingular Genomics Systems, Inc. | COM | 3,073,824 | $3,440 萬 | 0.5% | −9,046−0.3% | 減碼 | 歷史 |
| CYPHCypherpunk Technologies Inc. | COM | 8,476,496 | $3,399 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| TMCITreace Medical Concepts, Inc. | COM | 1,235,886 | $3,325 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| CMAXCareMax, Inc. | COM CL A | 3,385,000 | $3,270 萬 | 0.5% | +65,000+2.0% | 加碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 2,500,000 | $3,250 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| LONALeonaBio, Inc. | COM | 3,425,916 | $3,214 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 13,412,552 | $3,206 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 2,022,051 | $3,090 萬 | 0.5% | +343,078+20.4% | 加碼 | 歷史 |
| NVRONevro Corp | COM | 259,972 | $3,026 萬 | 0.4% | −558,788−68.2% | 減碼 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 3,041,004 | $3,023 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| HCATHealth Catalyst, Inc. | COM | 589,004 | $2,946 萬 | 0.4% | +22,920+4.0% | 加碼 | 歷史 |
| LYRALyra Therapeutics, Inc. | COM | 3,222,560 | $2,940 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 1,296,416 | $2,794 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 3,188,750 | $2,682 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 141,700 | $2,616 萬 | 0.4% | −475,102−77.0% | 減碼 | 歷史 |
| SLGCSomaLogic, Inc. | CLASS A COM | 2,050,000 | $2,540 萬 | 0.4% | +2,050,000 | 新進 | 歷史 |
| BCABBioAtla, Inc. | COM | 850,026 | $2,503 萬 | 0.4% | +164,507+24.0% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 1,423,000 | $2,341 萬 | 0.3% | +628,494+79.1% | 加碼 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 885,818 | $2,182 萬 | 0.3% | −193,210−17.9% | 減碼 | – |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 393,613 | $2,125 萬 | 0.3% | −349,086−47.0% | 減碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 615,000 | $2,027 萬 | 0.3% | −46,162−7.0% | 減碼 | 歷史 |
| WGSGeneDx Holdings Corp. | COMMON STOCK | 2,500,000 | $1,898 萬 | 0.3% | +2,500,000 | 新進 | 歷史 |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 491,332 | $1,883 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| HLTHCue Health Inc. | COM | 1,580,607 | $1,867 萬 | 0.3% | +1,580,607 | 新進 | 歷史 |
| IMRXImmuneering Corp | CLASS A COM | 681,051 | $1,808 萬 | 0.3% | +681,051 | 新進 | 歷史 |
| NTRANatera, Inc. | COM | 160,000 | $1,783 萬 | 0.3% | +160,000 | 新進 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 987,500 | $1,737 萬 | 0.3% | +987,500 | 新進 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 1,959,652 | $1,732 萬 | 0.3% | +1,959,652 | 新進 | 歷史 |
| ABSIAbsci Corp | COM | 1,476,776 | $1,718 萬 | 0.3% | +1,476,776 | 新進 | 歷史 |
| NUVLNuvalent, Inc. | COM | 750,000 | $1,691 萬 | 0.2% | +750,000 | 新進 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 2,888,889 | $1,583 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| AGRXAgile Therapeutics Inc | COM | 15,919,925 | $1,530 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ADMAAdma Biologics, Inc. | COM | 13,262,375 | $1,499 萬 | 0.2% | −3,322,427−20.0% | 減碼 | 歷史 |
| HYPRHyperfine, Inc. | CL A SHS | 1,500,000 | $1,485 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 400,000 | $1,483 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 875,093 | $1,434 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 781,236 | $1,406 萬 | 0.2% | −68,764−8.1% | 減碼 | 歷史 |
| BIIBBiogen Inc. | COM | 48,600 | $1,375 萬 | 0.2% | +48,600 | 新進 | 歷史 |
| VTRSViatris Inc | Stock | 1,004,419 | $1,361 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 556,047 | $1,320 萬 | 0.2% | −200,000−26.5% | 減碼 | 歷史 |
| CM Life Sciences III Inc125841205 | UNIT 04/30/2028 | 1,250,000 | $1,281 萬 | 0.2% | 00.0% | 不變 | – |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $1,280 萬 | 0.2% | – | – | – |
| PODDInsulet Corp | Stock | 44,522 | $1,265 萬 | 0.2% | +44,522 | 新進 | 歷史 |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,059,800 | $1,204 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ADPTAdaptive Biotechnologies Corp | COM | 352,804 | $1,199 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ACCDAccolade, Inc. | COM | 279,774 | $1,180 萬 | 0.2% | +34,033+13.8% | 加碼 | 歷史 |
| ZYZymergen Inc. | COM | 883,332 | $1,163 萬 | 0.2% | −750,000−45.9% | 減碼 | 歷史 |
| CLOVClover Health Investments, Corp. | COM CL A | 1,500,000 | $1,109 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ONEM1Life Healthcare Inc | COM | 532,350 | $1,078 萬 | 0.2% | +16,306+3.2% | 加碼 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 180,000 | $1,057 萬 | 0.2% | +180,000 | 新進 | 歷史 |
| ONCROncorus, Inc. | COM | 1,099,810 | $1,027 萬 | 0.1% | −363,789−24.9% | 減碼 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 375,256 | $1,012 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Summit Healthcre Acquistn CoG8566R128 | UNIT 06/03/2026 | 1,000,000 | $1,005 萬 | 0.1% | 00.0% | 不變 | – |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| ChemoCentryx, Inc.16383L106 | COM | – | $1,579 萬 |
| FLNAFilana Therapeutics, Inc. | COM | $620.8 萬 | – |
2021 年第 2 季之後清倉（34 檔）
2021 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 2 季股數 | 2021 年第 2 季市值 | 2021 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| KDMNKadmon Holdings, Inc. | COM | 15,711,334 | $6,080 萬 | 0.8% | 歷史 |
| MDTMedtronic plc | Stock | 450,000 | $5,586 萬 | 0.7% | 歷史 |
| DRNADicerna Pharmaceuticals Inc | COM | 800,000 | $2,986 萬 | 0.4% | 歷史 |
| EXASExact Sciences Corp | COM | 233,523 | $2,903 萬 | 0.4% | 歷史 |
| NARIInari Medical, Inc. | Stock | 310,437 | $2,896 萬 | 0.4% | 歷史 |
| XLRNAcceleron Pharma Inc | COM | 226,760 | $2,846 萬 | 0.4% | 歷史 |
| RGENRepligen Corp | COM | 132,500 | $2,645 萬 | 0.3% | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 315,141 | $2,610 萬 | 0.3% | 歷史 |
| COLLCollegium Pharmaceutical, Inc | COM | 978,277 | $2,313 萬 | 0.3% | 歷史 |
| FBRXForte Biosciences, Inc. | COM | 685,000 | $2,303 萬 | 0.3% | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 671,978 | $2,262 萬 | 0.3% | 歷史 |
| CM Life Sciences II Inc125842203 | UNIT 02/25/2028 | 1,250,000 | $1,681 萬 | 0.2% | – |
| Catabasis Pharmaceuticals IN14875P206 | COM NEW | 7,687,185 | $1,622 萬 | 0.2% | – |
| Therapeutics Acquisition Cor88339T103 | COM CL A | 1,500,000 | $1,541 萬 | 0.2% | – |
| CVRXCVRx, Inc. | COM | 440,000 | $1,232 萬 | 0.2% | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 1,640,957 | $1,039 萬 | 0.1% | 歷史 |
| SILKSilk Road Medical Inc | COM | 147,133 | $704.2 萬 | 0.1% | 歷史 |
| PRVAPrivia Health Group, Inc. | COM | 135,000 | $599.0 萬 | 0.1% | 歷史 |
| AKYAAkoya Biosciences, Inc. | COM | 300,000 | $580.2 萬 | 0.1% | 歷史 |
| BCTG Acquisition Corp05492W103 | COM | 500,000 | $569.0 萬 | 0.1% | – |
| MREOMereo BioPharma Group plc | SPON ADS | 1,696,068 | $537.7 萬 | 0.1% | 歷史 |
| Consonance HFW Acquisition CG2445M129 | UNIT 99/99/9999 | 500,000 | $520.0 萬 | 0.1% | – |
| Longview Acquisition Corp. II54319Q204 | UNIT 99/99/9999 | 500,000 | $504.0 萬 | 0.1% | – |
| MRUSMerus N.V. | COM | 175,000 | $368.7 萬 | <0.1% | 歷史 |
| AMWLAmerican Well Corp | CL A | 290,000 | $364.8 萬 | <0.1% | 歷史 |
| CM Life Sciences Inc18978W109 | COM CL A | 227,000 | $318.0 萬 | <0.1% | – |
| GRTXGalera Therapeutics, Inc. | COM | 254,664 | $250.3 萬 | <0.1% | 歷史 |
| Cerevel Therapeutics HLDNG I15678U102 | *W EXP 06/09/202 | 133,066 | $191.4 萬 | <0.1% | – |
| SGTXSigilon Therapeutics, Inc. | COM | 125,000 | $134.1 萬 | <0.1% | 歷史 |
| SRRASierra Oncology, Inc. | COM NEW | 66,655 | $129.8 萬 | <0.1% | 歷史 |
| SC Health CorpG78516401 | *W EXP 99/99/999 | 500,000 | $105.5 萬 | <0.1% | – |
| PLXPPLx Pharma Winddown Corp. | COM | 57,459 | $79.3 萬 | <0.1% | 歷史 |
| TKNOAlpha Teknova, Inc. | COM | 30,000 | $71.2 萬 | <0.1% | 歷史 |
| TCRRTCR2 Therapeutics Inc. | COM | 30,753 | $50.5 萬 | <0.1% | 歷史 |